Health In Tech, Inc.
Health In Tech is an AI-enabled health insurance technology platform serving employers, insurance carriers, licensed brokers, managing general underwriters and third-party administrators. Its marketplace lets carriers list stop-loss policies for self-funded benefits plans, while brokers can select plans, submit employer information and obtain bindable quotes. The company also provides customized health plan design and related vendor, claims and network services, primarily through subsidiaries Stone Mountain Risk and International Captive Exchange. Its eDIYBS platform supports medical underwriting and quoting, and HI Card is an optional platform for managing benefits information and claims, with access to the HI Performance Network. Health In Tech earns fees from employers and carriers when brokers or TPAs sell stop-loss policies and self-funded plans. Stone Mountain Risk receives service fees, International Captive Exchange earns underwriting fees on premiums, and HI Card receives fees for its optional services. The company is headquartered in Stuart, Florida.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Health In Tech (Nasdaq: HIT) reported Q3 2026 revenue of $6.6M, down from $8.5M in Q3 2025. Nine-month revenue was $23.4M, down from $25.8M. Contracted revenue was $32.7M, with $6.1M expected in Q4 2026. Pipeline revenue was $156.4M. Net loss was $7.1M, or $(0.11) per share, up from a $0.5M profit in Q3 2025. CEO Sanjay Shrestha outlined growth plans, including improving conversion rates and evaluating acquisitions.
Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On November 10, 2026, Health In Tech, Inc. (the “Company”) (Nasdaq: HIT) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). For more information on the proposals, which are described below, please re
Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. As previously disclosed, on August 12, 2026, Health In Tech, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) and a related Registration Rights Agreement. On September 4, 2026, the Company sa
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning HIT (Health In Tech, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent HIT coverage spans corporate actions, financial news and earnings.
In the last 30 days, HIT insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($3K). The most active reporter was Hasan Zain Syed, Chief Growth Officer, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Earnings miss and guidance cut likely trigger sell pressure.
Potential dilution from increased authorized shares and SEPA issuance may pressure the stock price.
The financing provides near‑term cash but dilutes equity if converted; short‑term price may see modest upside as liquidity improves, but conversion caps limit upside.
Executive leadership change may cause short‑term stock volatility as investors reassess management.
Leadership transition may cause short‑term volatility as investors evaluate the new CEO's track record.
AlphAI scores every news story that mentions HIT with an AI model for sentiment and relevance, and aggregates insider trades from Health In Tech, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Health In Tech (Nasdaq: HIT) reported Q3 2026 revenue of $6.6M, down from $8.5M in Q3 2025. Nine-month revenue was $23.4M, down from $25.8M. Contracted revenue was $32.7M, with $6.1M expected in Q4 2026. Pipeline revenue was $156.4M. Net loss was $7.1M, or $(0.11) per share, up from a $0.5M profit in Q3 2025. CEO Sanjay Shrestha outlined growth plans, including improving conversion rates and evaluating acquisitions.
Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On November 10, 2026, Health In Tech, Inc. (the “Company”) (Nasdaq: HIT) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). For more information on the proposals, which are described below, please re
Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. As previously disclosed, on August 12, 2026, Health In Tech, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) and a related Registration Rights Agreement. On September 4, 2026, the Company sa
Health In Tech (HIT) appointed Sanjay Shrestha as CEO, effective October 20, 2026. Tim Johnson, the former CEO, transitioned to Executive Chairman. Shrestha's employment agreement includes a $500,000 base salary, with potential increases and bonuses.
Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion · Founder Tim Johnson to become Executive Chairman, continuing to drive long-term strategy, technology innovation and product development · Leaders
Health In Tech (HIT) named Sanjay Shrestha as CEO, with founder Tim Johnson becoming Executive Chairman. Shrestha previously led Plug Power and will focus on operations and growth. The company plans to expand its AI-enabled InsurTech platform and explore acquisitions.
Nasdaq notified Health In Tech (HIT) it failed to meet independent director and audit committee requirements, with a cure period until August 10, 2027. Additionally, its stock failed the $1.00 minimum bid price rule, with 180 days to comply, possibly via a reverse stock split. Trading remains unaffected.
Health In Tech (Nasdaq: HIT) launched HitRix, an AI-powered platform for brokers to place self-funded medical stop-loss insurance. The tool streamlines submission, market routing, and quote comparison, reducing manual work and errors. HitRix aims to improve efficiency and decision-making for brokers and market partners.
Health In Tech (Nasdaq: HIT) launched HitRix, an AI-powered platform to streamline large-group self-funded health insurance workflows. The company updated its 2026 revenue outlook to $33 million, in line with 2025. Growth is expected to accelerate in 2027 from HitRix, a Three-Year Rate Stabilization Program, and expanded carrier capacity.
Health In Tech (HIT) reported Q2 2026 revenue of $8.1M, down 13.5% YoY due to policy timing shifts. Distribution partners grew 19.9% to 933. Contracted revenue was $32.3M, with $14M expected in H2 2026. Pipeline revenue reached $66.3M. Adjusted EBITDA was -$1.3M, and net loss was $2.5M. Management reaffirmed full-year guidance of $45M-$50M revenue, citing strong pipeline visibility. The company is investing in sales, marketing, and technology upgrades, including the upcoming HitRix platform for
